Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 12.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $2.602 million which beat the analyst consensus estimate of $1.606 million by 62.04 percent. This is a 107.00 percent increase over sales of $1.257 million the same period last year.